Related Experiment Video
Updated: Jan 22, 2026

Visualizing Dengue Virus through Alexa Fluor Labeling
Published on: July 9, 2011
Study of Hepatic Involvement and Thrombocytopenia in Dengue
Neelakanth S Patil1, Neelam N Redkar2, Vikram Londhey3
1Assistant Professor, SDM College of Medical Sciences and Hospital Sattur, Dharwad, Karnataka.
Objective:
The purpose of this study was to assess the pattern of hepatic involvement and thrombocytopenia in patients with dengue fever and time taken for clinical/biochemical recovery.
Methods:
This is a retrospective study done in a tertiary centre. A total of 1111 patients with documented dengue fever, either with NS1 antigen/IgM antibody positive report who were admitted between January 2016 to December 2016.The aminotransferase levels and platelet counts were measured on day 1,4 and7. Patients were assessed clinically on day 1,4,7 or till discharge/death accordingly.
Conclusion:
Out of 1111 patients with dengue infection, 993 had either thrombocytopenia or hepatic involvement or both. Majority of patients with thrombocytopenia and hepatic dysfunction recovered between 4-7 days of admission i.e 53.98% and 29.20%. Statistically significant corelation of platelet count and aminotransferase levels with recovery or death of the patient was seen in our study.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Hepatic Drug Excretion: Influencing Factors
Hepatic Drug Clearance: Role of Transporters

